Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, November 6, 2020
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
[ Fri, Nov 06th 2020
] - WOPRAI
Geoffrey Porges Maintained (TBPH) at Buy with Decreased Target to $35 on, Nov 6th, 2020
Geoffrey Porges of SVB Leerink, Maintained "Theravance Biopharma, Inc." (TBPH) at Buy with Decreased Target from $40 to $35 on, Nov 6th, 2020.
Geoffrey has made no other calls on TBPH in the last 4 months.
There are 3 other peers that have a rating on TBPH. Out of the 3 peers that are also analyzing TBPH, 0 agree with Geoffrey's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Geoffrey
- Vikram Purohit of "Morgan Stanley" Upgraded from Hold to Buy on, Wednesday, October 14th, 2020
- Tyler Van Buren of "Piper Sandler" Maintained at Buy with Decreased Target to $30 on, Monday, August 10th, 2020
- Anupam Rama of "JP Morgan" Initiated at Buy and Held Target at $29 on, Tuesday, July 7th, 2020
